Literature DB >> 30113687

Folate Receptor Overexpression in Human and Canine Meningiomas-Immunohistochemistry and Case Report of Intraoperative Molecular Imaging.

John T Pierce1, Steve S Cho1,2, Shayoni Nag1, Ryan Zeh1, Jun Jeon1,2, David Holt3, Amy Durham4, MacLean P Nasrallah5, Sunil Singhal6, John Y K Lee1.   

Abstract

BACKGROUND: Meningiomas are well-encapsulated benign brain tumors and surgical resection is often curative. Nevertheless, this is not always possible due to the difficulty of identifying residual disease intraoperatively. We hypothesized that meningiomas overexpress folate receptor alpha (FRα), allowing intraoperative molecular imaging by targeting FRα with a near-infrared (NIR) dye.
OBJECTIVE: To determine FRα expression in both human and canine meningioma cohorts to prepare for future clinical studies. Present a case study of a meningioma resection with intraoperative NIR fluorescence imaging.
METHODS: Tissue samples of 27 human meningioma specimens and 7 canine meningioma specimens were immunohistochemically stained for FRα along with normal dura, skeletal muscle, and kidney tissue. We then enrolled a patient with a pituitary adenoma and tuberculum sella meningioma in a clinical trial in which the patient received an infusion of folate-linked, NIR fluorescent dye prior to surgery.
RESULTS: In the cohort of human meningiomas, 9 WHO grade I, 12 grade II, and 6 grade III tumors were identified. Eighty-nine percent of WHO grade I, 67% of grade II, and 50% of grade III tumors overexpressed FRα. In the 7 canine meningioma samples, 100% stained positively for FRα. Both human and canine normal dura from autopsy samples demonstrated no evidence of FRα overexpression. In the case study, the meningioma demonstrated a high NIR signal-to-background-ratio of 4.0 and demonstrated strong FRα immunohistochemistry staining.
CONCLUSION: This study directly demonstrates FRα overexpression in both human and canine meningiomas. We also demonstrate superb intraoperative imaging of a meningioma using a FRα-targeting dye.
Copyright © 2018 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Canine; Folate-receptor; Immunohistochemistry staining; Meningioma; Near-infrared imaging

Mesh:

Substances:

Year:  2019        PMID: 30113687      PMCID: PMC6904722          DOI: 10.1093/neuros/nyy356

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  28 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging.

Authors:  John Y K Lee; Steve S Cho; Ryan Zeh; John T Pierce; Maria Martinez-Lage; Nithin D Adappa; James N Palmer; Jason G Newman; Kim O Learned; Caitlin White; Julia Kharlip; Peter Snyder; Philip S Low; Sunil Singhal; M Sean Grady
Journal:  J Neurosurg       Date:  2017-08-25       Impact factor: 5.115

Review 3.  Body mass index, physical activity, and risk of adult meningioma and glioma: A meta-analysis.

Authors:  Tobias Niedermaier; Gundula Behrens; Daniela Schmid; Inga Schlecht; Beate Fischer; Michael F Leitzmann
Journal:  Neurology       Date:  2015-09-16       Impact factor: 9.910

Review 4.  Folate receptors.

Authors:  A C Antony
Journal:  Annu Rev Nutr       Date:  1996       Impact factor: 11.848

5.  Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: technical case report.

Authors:  Yoichi Morofuji; Takayuki Matsuo; Yukishige Hayashi; Kazuhiko Suyama; Izumi Nagata
Journal:  Neurosurgery       Date:  2008-03       Impact factor: 4.654

6.  Sorting of the human folate receptor in MDCK cells.

Authors:  Chong-Ho Kim; Young-Soon Park; Koong-Nah Chung; P C Elwood
Journal:  J Biochem Mol Biol       Date:  2004-05-31

7.  Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.

Authors:  Ronald E Fisher; Barry A Siegel; Steven L Edell; Nelson M Oyesiku; David E Morgenstern; Richard A Messmann; Robert J Amato
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

Review 8.  Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.

Authors:  T John; G Liu; M-S Tsao
Journal:  Oncogene       Date:  2009-08       Impact factor: 9.867

9.  Meningioma: analysis of recurrence and progression following neurosurgical resection.

Authors:  R O Mirimanoff; D E Dosoretz; R M Linggood; R G Ojemann; R L Martuza
Journal:  J Neurosurg       Date:  1985-01       Impact factor: 5.115

10.  Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.

Authors:  Leonora S F Boogerd; Charlotte E S Hoogstins; Katja N Gaarenstroom; Cornelis D de Kroon; Jogchum J Beltman; Tjalling Bosse; Ellen Stelloo; Jaap Vuyk; Philip S Low; Jacobus Burggraaf; Alexander L Vahrmeijer
Journal:  Oncotarget       Date:  2017-12-11
View more
  3 in total

1.  PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe.

Authors:  Xiaojing Shi; Pengfei Xu; Caiguang Cao; Zhen Cheng; Jie Tian; Zhenhua Hu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-15       Impact factor: 10.057

2.  Indocyanine-Green for Fluorescence-Guided Surgery of Brain Tumors: Evidence, Techniques, and Practical Experience.

Authors:  Steve S Cho; Ryan Salinas; John Y K Lee
Journal:  Front Surg       Date:  2019-03-12

Review 3.  Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors.

Authors:  Andrew D Miller; C Ryan Miller; John H Rossmeisl
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.